相似文献
1
The colony-stimulating factors and cancer.
Nat Rev Cancer. 2010 Jun;10(6):425-34. doi: 10.1038/nrc2843.
2
Colony-stimulating factors for the management of neutropenia in cancer patients.
Drugs. 2002;62 Suppl 1:1-15. doi: 10.2165/00003495-200262001-00001.
3
Hematopoietic recovery following high-dose combined alkylating-agent chemotherapy and autologous bone marrow support in patients in phase-I clinical trials of colony-stimulating factors: G-CSF, GM-CSF, IL-1, IL-2, M-CSF.
Ann Hematol. 1993 Dec;67(6):267-76. doi: 10.1007/BF01696346.
4
5
Granulocyte-macrophage colony-stimulating factor (GM-CSF) in the management of cancer.
In Vivo. 1991 Nov-Dec;5(6):571-7.
6
7
Colony stimulating factors (including erythropoietin, granulocyte colony stimulating factor and analogues) for stroke.
Cochrane Database Syst Rev. 2013 Jun 24;2013(6):CD005207. doi: 10.1002/14651858.CD005207.pub4.
8
The promise of colony-stimulating factors in clinical practice.
Oncol Nurs Forum. 1990 Jan-Feb;17(1 Suppl):20-4.
9
[High dose chemotherapy in malignant gliomas using autologous bone marrow transplantation and GM-CSF: granulocyte-macrophage colony stimulating factors].
No Shinkei Geka. 1990 Apr;18(4):329-38.
10
[Application of CSF to cancer treatment].
Gan To Kagaku Ryoho. 1988 Apr;15(4 Pt 2-1):739-46.
引用本文的文献
1
Nanoparticle approaches for manipulating cytokine delivery and neutralization.
Front Immunol. 2025 Jun 10;16:1592795. doi: 10.3389/fimmu.2025.1592795. eCollection 2025.
2
Alleviation of Microglia Mediating Hippocampal Neuron Impairments and Depression-Related Behaviors by Urolithin B via the SIRT1-FOXO1 Pathway.
CNS Neurosci Ther. 2025 Apr;31(4):e70379. doi: 10.1111/cns.70379.
3
Proinflammatory Cytokines in Chronic Respiratory Diseases and Their Management.
Cells. 2025 Mar 9;14(6):400. doi: 10.3390/cells14060400.
4
Granulocyte-Macrophage Colony Stimulating Factor Receptor Contributes to Plexiform Neurofibroma Initiation.
Cancers (Basel). 2025 Mar 6;17(5):905. doi: 10.3390/cancers17050905.
5
Taxane-Associated Acute Pain Syndrome: a Review of its Features and Management.
Curr Treat Options Oncol. 2025 Mar;26(3):187-196. doi: 10.1007/s11864-025-01302-y. Epub 2025 Feb 28.
6
CSF3 promotes colorectal cancer progression by activating p65/NF-κB signaling pathway and inducing an immunosuppressive microenvironment.
Transl Oncol. 2025 Mar;53:102310. doi: 10.1016/j.tranon.2025.102310. Epub 2025 Feb 9.
7
Effect of colony‑stimulating factor in the mechanism of bone metastasis development (Review).
Oncol Rep. 2024 Dec;52(6). doi: 10.3892/or.2024.8824. Epub 2024 Oct 18.
8
Review of COVID-19 Therapeutics by Mechanism: From Discovery to Approval.
J Korean Med Sci. 2024 Apr 15;39(14):e134. doi: 10.3346/jkms.2024.39.e134.
9
Yeasts as Biopharmaceutical Production Platforms.
Front Fungal Biol. 2021 Sep 22;2:733492. doi: 10.3389/ffunb.2021.733492. eCollection 2021.
10
Cytokines as Biomarkers for Evaluating Physical Exercise in Trained and Non-Trained Individuals: A Narrative Review.
Int J Mol Sci. 2023 Jul 6;24(13):11156. doi: 10.3390/ijms241311156.
本文引用的文献
1
Forcing cells to change lineages.
Nature. 2009 Dec 3;462(7273):587-94. doi: 10.1038/nature08533.
2
Murine hematopoietic blast colony-forming cells and their progeny have distinctive membrane marker profiles.
Proc Natl Acad Sci U S A. 2009 Nov 10;106(45):19102-7. doi: 10.1073/pnas.0910354106. Epub 2009 Oct 23.
3
Anemia management in oncology and hematology.
Oncologist. 2009;14 Suppl 1:43-56. doi: 10.1634/theoncologist.2009-S1-43.
4
Safety and efficacy of hematopoietic stem cell collection from mobilized peripheral blood in unrelated volunteers: 12 years of single-center experience in 3928 donors.
Blood. 2009 Oct 29;114(18):3757-63. doi: 10.1182/blood-2009-04-218651. Epub 2009 Aug 7.
5
Use of filgrastim and pegfilgrastim to support delivery of chemotherapy: twenty years of clinical experience.
BioDrugs. 2009;23(3):175-86. doi: 10.2165/00063030-200923030-00004.
6
Hematopoietic cytokines can instruct lineage choice.
Science. 2009 Jul 10;325(5937):217-8. doi: 10.1126/science.1171461.
7
Hematopoietic colony-stimulating factors mediate tumor-nerve interactions and bone cancer pain.
Nat Med. 2009 Jul;15(7):802-7. doi: 10.1038/nm.1976. Epub 2009 Jun 7.
8
Should the indications for the use of myeloid growth factors for the prevention of febrile neutropenia in cancer patients be extended?
Curr Opin Oncol. 2009 Jul;21(4):297-302. doi: 10.1097/CCO.0b013e32832c9651.
9
Cytokine gene-mediated immunotherapy: current status and future perspectives.
Cancer Sci. 2009 Aug;100(8):1389-96. doi: 10.1111/j.1349-7006.2009.01202.x. Epub 2009 May 13.
10
The granulocyte-macrophage colony-stimulating factor receptor: linking its structure to cell signaling and its role in disease.
Blood. 2009 Aug 13;114(7):1289-98. doi: 10.1182/blood-2008-12-164004. Epub 2009 May 12.
Zotero 插件